Abattis Bioceuticals Corp Stock Return On Equity
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Abattis Bioceuticals Corp fundamentals help investors to digest information that contributes to Abattis Bioceuticals' financial success or failures. It also enables traders to predict the movement of Abattis Pink Sheet. The fundamental analysis module provides a way to measure Abattis Bioceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abattis Bioceuticals pink sheet.
Abattis |
Abattis Bioceuticals Corp Company Return On Equity Analysis
Abattis Bioceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Abattis Bioceuticals Return On Equity | -0.28 |
Most of Abattis Bioceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abattis Bioceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Abattis Bioceuticals Corp has a Return On Equity of -0.2813. This is 98.83% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 9.26% lower than that of the firm.
Abattis Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abattis Bioceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Abattis Bioceuticals could also be used in its relative valuation, which is a method of valuing Abattis Bioceuticals by comparing valuation metrics of similar companies.Abattis Bioceuticals is currently under evaluation in return on equity category among related companies.
Abattis Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (10.96) % | |||
| Current Valuation | 4.08 M | |||
| Shares Outstanding | 477.8 M | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (5.83) X | |||
| Price To Book | 0.38 X | |||
| Price To Sales | 1.33 X | |||
| Revenue | 356.88 K | |||
| Gross Profit | 241.34 K | |||
| EBITDA | (2.9 M) | |||
| Net Income | (3.04 M) | |||
| Cash And Equivalents | 2.4 M | |||
| Total Debt | 150.86 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.73 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 9.41 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 32 | |||
| Beta | -60.6 | |||
| Market Capitalization | 473.03 K | |||
| Total Asset | 19.26 M | |||
| Retained Earnings | (10.13 M) | |||
| Working Capital | (588 K) | |||
| Current Asset | 260 K | |||
| Current Liabilities | 848 K | |||
| Z Score | 1.8 | |||
| Net Asset | 19.26 M |
About Abattis Bioceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abattis Bioceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abattis Bioceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abattis Bioceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Abattis Bioceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abattis Bioceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abattis Bioceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abattis Bioceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abattis Bioceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abattis Bioceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abattis Bioceuticals Corp to buy it.
The correlation of Abattis Bioceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abattis Bioceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abattis Bioceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abattis Bioceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abattis Bioceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Abattis Bioceuticals Corp information on this page should be used as a complementary analysis to other Abattis Bioceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Abattis Pink Sheet analysis
When running Abattis Bioceuticals' price analysis, check to measure Abattis Bioceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abattis Bioceuticals is operating at the current time. Most of Abattis Bioceuticals' value examination focuses on studying past and present price action to predict the probability of Abattis Bioceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abattis Bioceuticals' price. Additionally, you may evaluate how the addition of Abattis Bioceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |